ArticleFrontiers in oncology2024

A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma.

Rahul Ladwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.